✦ LIBER ✦

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: A randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group

✍ Scribed by Leilani Morales; Peter Canney; Jaroslaw Dyczka; Emiel Rutgers; Robert Coleman; Tanja Cufer; Marzena Welnicka-Jaskiewicz; Johan Nortier; Jan Bogaerts; Patrick Therasse; Robert Paridaens

Book ID: 116429200
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 201 KB
Volume: 43
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2006.10.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postoperative adjuvant chemotherapy foll

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901

✍ R Paridaens; J Dyczka; E.J.T Rutgers; R Coleman; T Cufer; J Jassem; J.W.R Nortie 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Postoperative adjuvant randomised trial

Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the nishinihon cooperative study group of adjuvant chemoendocrine therapy for breast cancer (ACETBC) of Japan

✍ T. Morimoto; M. Ogawa; K. Orita; K. Sugimachi; T. Toge; K. Dohi; Y. Nomura; Y. M 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 899 KB

Phase III randomised study to evaluate t

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)

✍ N.S. Reed; C. Mangioni; H. Malmström; G. Scarfone; A. Poveda; S. Pecorelli; S. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 370 KB

Strontium89 Chloride versus Palliative L

Strontium89 Chloride versus Palliative Local Field Radiotherapy in Patients with Hormonal Escaped Prostate Cancer: A Phase III Study of the European Organisation for Research and Treatment of Cancer Genitourinary Group

✍ G.O.N. Oosterhof; J.T. Roberts; Th.M. de Reijke; S.A. Engelholm; S. Horenblas; H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Fifteen-year median follow-up results af

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

✍ G. G. Kimmick; C. Cirrincione; D. B. Duggan; K. Bhalla; N. Robert; D. Berry; L. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 325 KB

Corrigendum to “Phase III randomised stu

Corrigendum to “Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)” [European Journal of Cancer, 44 (2008) 808–818]

✍ N.S. Reed; C. Mangioni; H. Malmström; G. Scarfone; A. Poveda; S. Pecorelli; S. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB